Oxolinic acid

Revision as of 02:17, 9 January 2014 by Gerald Chi (talk | contribs)
Jump to navigation Jump to search
Oxolinic acid
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H11NO5
Molar mass261.23 g/mol
 ☒N☑Y (what is this?)  (verify)


Overview

Oxolinic acid is a quinolone antibiotic developed in Japan in the 1970s.[1][2] Dosages 12–20 mg/kg orally administered for five to ten days. The antibiotic works by inhibiting the enzyme DNA gyrase. It also acts as a dopamine reuptake inhibitor and has stimulant effects in mice.[3]

Category

Brand Names

Mechanism of Action

See also

References

  1. JP Patent 49138244
  2. Gleckman R, Alvarez S, Joubert DW, Matthews SJ (1979). "Drug therapy reviews: oxolinic acid". American Journal of Hospital Pharmacy. 36 (8): 1077–9. PMID 384788. Unknown parameter |month= ignored (help)
  3. Garcia de Mateos-Verchere J, Vaugeois JM, Naudin B, Costentin J (1998). "Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 8 (4): 255–9. doi:10.1016/S0924-977X(97)00083-7. PMID 9928913. Unknown parameter |month= ignored (help)